Access Genetics Partners with Caliper to Offer LapChip(R) GX as Molecular Diagnostic Solution

HOPKINTON, Mass., April 13 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today announced a non-exclusive original equipment manufacturer (OEM) agreement with Access Genetics to market Caliper's LabChip GX microfluidic system for molecular diagnostic applications.

Access Genetics has worked for more than a decade developing and implementing solutions enabling the delivery of molecular diagnostics.  As part of this agreement, Access Genetics will incorporate web-based software, materials and protocols that Access Genetics developed specifically for use with the LabChip GX and market the combined platform's benefits to a wide community of clinicians, pathologists, and physicians.  The LabChip GX system provides laboratories, offering DNA-diagnostic testing, an innovative platform for automating numerous molecular tests on a common instrument system.

"For 10 years we have awaited an instrument platform that realizes the potential of miniaturized DNA-based diagnostics," said Dr. Ron McGlennen, founder, President, and Medical Director of Access Genetics.  "The LabChip GX platform is a versatile and economical solution for clinical molecular applications."

"Our partnership with Access Genetics should accelerate adoption of LabChip GX instruments in the attractive and evolving molecular diagnostic market," said Kevin Hrusovsky, President and CEO, Caliper Life Sciences. "We look forward to working with Access Genetics to optimize LabChip technology for diagnostics applications."

Caliper's LabChip GX system is an advanced automated electrophoresis instrument that utilizes microfluidics chip-based technology to provide high-resolution nucleic acid analysis. Caliper's portfolio of patented microfluidic tools and technologies, including chips, instrument design, and software for data displays and analysis, is changing the way diagnostics and research is performed in laboratories by providing faster, more reproducible and more accurate data.

About Access Genetics

Access Genetics, a Minnesota-based company, provides web-based software, laboratory materials, and networked expertise working seamlessly to improve molecular diagnostics and patient care. Access Genetics' proprietary web-based software, TeleGene™, synergistically integrates web-enabled molecular diagnostics, collaborative telemedicine, and turnkey support and materials management. TeleGene™ is the cornerstone of a unique business model that provides physicians and clinical laboratories the means to become experts in molecular diagnostics and, in turn, rapidly expand their offering of high-value, in-house genetic tests. For more information please visit www.access-genetics.com.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation and liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper and LabChip are registered trademarks of Caliper Life Sciences, Inc.  TeleGene is a trademark of Access Genetics.

SOURCE Caliper Life Sciences, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED